Name:Cas9 crRNA-3 Sequence:/AltR1/rGrG rGrCrG rArGrG rArGrC rUrGrU rUrCrA rCrCrG rGrUrU rUrUrA… and 5 more items

The University of Virginia awarded a purchase order (PO-0455371) to Integrated DNA Technologies Inc. on August 1, 2026, for the procurement of molecular biology research reagents with a total contract value of $316.00. The award encompasses six distinct line items consisting of clustered regularly interspaced short palindromic repeats (CRISPR)-based molecular tools and DNA oligonucleotides, totaling 312 units across all items. The specific products include Alt-R CRISPR-Cas9 complementary RNA (crRNA) sequences in two variants, Alt-R Actinobacillus species Cas12a crRNA sequences in two variants, and synthesized DNA oligonucleotides (GFP-forward and GFP-reverse) designed for molecular cloning applications, all manufactured with standard desalting purification methods.

All line items are designated for delivery to the University of Virginia as the buyer in Virginia. The procurement specifications indicate this is supporting molecular biology research, likely involving genetic engineering or gene expression studies utilizing CRISPR technology platforms. With unit prices of $1.00 per item across all six line items and the cumulative contract value of $316.00, this award represents a relatively modest research supply purchase consistent with academic laboratory consumable procurement patterns.